Clinical Trial Update: Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated memantine for preventing cognitive late effects in pediatric patients undergoing cranial radiation therapy for localized brai…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Craniopharyngioma
• Ependymoma
• Germ Cell Tumor
• Glioma of Brain

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Glioma of Brain, Craniopharyngioma | Phase 2 | Status: COMPLETED